UV protection and sunscreens: What to tell patients

Cleveland Clinic Journal of Medicine

Volumn 79, Issue 6, 2012, Pages 427-436

  Jou, Paul C ^a   Feldman, Ron J ^b   Tomecki, Kenneth J ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

CLASSIFICATION; FOOD AND DRUG ADMINISTRATION; HUMAN; PACKAGING; PRACTICE GUIDELINE; RADIATION EXPOSURE; REVIEW; SKIN; SKIN TUMOR; STANDARD; SUNBATHING; SUNLIGHT; ULTRAVIOLET RADIATION; UNITED STATES;

GUIDELINES AS TOPIC; HUMANS; PRODUCT LABELING; SKIN; SKIN NEOPLASMS; SUNBATHING; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84863003051     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.79a.11110     Document Type: Review

References (53)

1. Kullavanijaya P, Lim HW. 2005 Photoprotection. J Am Acad Dermatol 52, 937-958.
2. Sivamani RK, Ghiya M, Maibach HI. 2010 Shedding light on sunscreens and their labels: testing policies need to match actual use. Am J Prev Med 38, 679-681.
3. Miyamura Y, Coelho SG, Schlenz K, et al. 2011 The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin. Pigment Cell Melanoma Res 24, 136-147.
4. American Cancer Society. What are the key statistics about basal and squamous cell skin cancers? http://www.cancer.org/Cancer/ SkinCancer-BasalandSquamousCell/DetailedGuide/skin-cancer-basaland-squamous-cell-key-statistics. Accessed May 9 2012
5. American Cancer Society. What are the key statistics about melanoma? http://www.cancer.org/Cancer/SkinCancer-Melanoma/ DetailedGuide/melanoma-skin-cancer-key-statistics. Accessed May 9 2012
6. Jou PC, McCormick TS, Baron ED. 2011 UV immunosuppression and cutaneous malignancies. Expert Rev Dermatol 6, 61-74.
7. Wang Y, Digiovanna JJ, Stern JB, et al. 2009 Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A 106, 6279-6284.
8. Yano K, Kadoya K, Kajiya K, Hong YK, Detmar M. 2005 Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br J Dermatol 152, 115-121.
9. Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN. 2006 Photoaging: mechanisms and repair. J Am Acad Dermatol 55, 1-19.
10. Damian DL, Patterson CR, Stapelberg M, Park J, Barnetson RS, Halliday GM. 2008 UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 128, 447-454.
11. Miller SA, Hamilton SL, Wester UG, Cyr WH. 1998 An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem Photobiol 68, 63-70.
12. Seité S, Fourtanier AM. 2008 The benefit of daily photoprotection. J Am Acad Dermatol 58[5 suppl 2], S160-166.
13. Besaratinia A, Synold TW, Chen HH, et al. 2005 DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A 102, 10058-10063.
14. May P, May E. 1999 Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18, 7621-7636.
15. Mouret S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T. 2006 Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci USA 103, 13765-13770.
16. Wolber R, Schlenz K, Wakamatsu K, et al. 2008 Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res 21, 487-491.
17. Miyamura Y, Coelho SG, Wolber R, et al. 2007 Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res 20, 2-13.
18. Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, Belch GE. 2002 Promotion of frequent tanning sessions by indoor tanning facilities: two studies. J Am Acad Dermatol 46, 700-705.
19. Dellavalle RP, Parker ER, Cersonsky N, et al. 2003 Youth access laws: in the dark at the tanning parlor? Arch Dermatol 139, 443-448.
20. Whitmore SE, Morison WL, Potten CS, Chadwick C. 2001 Tanning salon exposure and molecular alterations. J Am Acad Dermatol 44, 775-780.
21. Swerdlow AJ, Weinstock MA. 1998 Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 38, 89-98.
22. IBISWorld. Tanning salons in the US: Market research report NAICS 81219c. www.ibisworld.com. Accesssed May 9 2012
23. American Academy of Dermatology Tanning Website. Stats and facts. Prevention and care. Indoor tanning. http://www.aad.org/ media-resources/stats-and-facts/prevention-and-care/indoor-tanning. Accessed May 9 2012
24. Lautenschlager S, Wulf HC, Pittelkow MR. 2007 Photoprotection. Lancet 370, 528-537.
25. Burnett ME, Wang SQ. 2011 Current sunscreen controversies: a critical review. Photodermatol Photodermatol Photoimmunol Photomed Apr 27(2), 58-67.
26. US Food and Drug Administration (FDA). CFR - Code of Federal Regulations Title 21, Chapter 1, Part 352: Sunscreen drug products for over-the-counter human use. http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=352. Accessed May 9 2012
27. Wang SQ, Lim HW. 2011 Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration's final rule on labeling and effectiveness testing. J Am Acad Dermatol 65, 863-869.
28. Food and Drug Administration (FDA). Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use (final rule). Federal Register 2011. http://www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14766.pdf. Accessed May 9 2012
29. Scherschun L, Lim HW. 2001 Photoprotection by sunscreens. Am J Clin Dermatol 2, 131-134.
30. US Food and Drug Administration(FDA). Sunburn protection factor (SPF). http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/ CDER/ucm106351.htm. Accessed May 9 2012
31. 1994 DeSimone EM 2nd. FDA proposes changes in sunscreen regulations. Am Pharm NS34, 26-31.
32. US Food and Drug Administration (FDA). Questions and answers: FDA announces new requirements for over-the-counter (OTC) sunscreen products marketed in the US (updated 6/23/11). http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicine-Safely/UnderstandingOver-the-CounterMedicines/ucm258468.htm. Accessed May 9
33. 2012 US Food and Drug Administration (FDA). FDA Press Release. FDA announces changes to better inform consumers about sunscreen: new rules give consumers more information to help reduce the risk of skin cancer, early aging. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm258940.htm. Accessed May 9
34. Autier P. 2009 Sunscreen abuse for intentional sun exposure. Br J Dermatol 161(suppl 3), 40-45.
35. Baron ED, Fourtanier A, Compan D, Medaisko C, Cooper KD, Stevens SR. 2003 High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans. J Invest Dermatol 121, 869-875.
36. Moyal DD, Fourtanier AM. 2008 Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol 58(suppl 2), S149-S154.
37. Boyd AS, Naylor M, Cameron GS, Pearse AD, Gaskell SA, Neldner KH. 1995 The effects of chronic sunscreen use on the histologic changes of dermatoheliosis. J Am Acad Dermatol 33, 941-946.
38. Young AR, Orchard GE, Harrison GI, Klock JL. 2007 The detrimental effects of daily sub-erythemal exposure on human skin in vivo can be prevented by a daily-care broad-spectrum sunscreen. J Invest Dermatol 127, 975-978.
39. Thompson SC, Jolley D, Marks R. 1993 Reduction of solar keratoses by regular sunscreen use. N Engl J Med 329, 1147-1151.
40. Green A, Williams G, Neale R, et al. 1999 Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354, 723-729.
41. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. 2006 Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 15, 2546-2548.
42. Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI, Coldman AJ. 2000 Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA 283, 2955-2960.
43. Autier P, Doré JF, Cattaruzza MS, et al. 1998 Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 90, 1873-1880.
44. Dennis LK, Beane Freeman LE, VanBeek MJ. 2003 Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 139, 966-978.
45. Green AC, Williams GM, Logan V, Strutton GM. 2011 Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 29, 257-263.
46. Goldenhersh MA, Koslowsky M. 2011 Increased melanoma after regular sunscreen use? J Clin Oncol 29, e557-e558.
47. American Academey of Dermatology Sunscreen Website. Stats and facts. Prevention and care. Sunscreens. http://www.aad.org/mediaresources/ stats-and-facts/prevention-and-care/sunscreens. Accessed May 9
48. Neale R, Williams G, Green A. 2002 Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 138, 1319-1325.
49. Paller AS, Hawk JL, Honig P, et al. 2011 New insights about infant and toddler skin: implications for sun protection. Pediatrics 128, 92-102.
50. American Academy of Pediatrics. HealthyChildren. Safety & prevention: Sun safety. http://www.healthychildren.org/english/safetyprevention/at-play/pages/Sun-Safety.aspx. Accessed May 9
51. US Food and Drug Administration (FDA). Information for consumers (drugs). Sunscreen. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/ucm239463.htm. Accessed May 9
52. Food and Drug Administration (FDA). Revised effectiveness determination; Sunscreen drug products for over-the-counter human use (proposed rule.) Federal Register 2011. http://69.175.53.6/register/2011/jun/17/2011-14769.pdf. Accessed May 9
53. Food and Drug Administration (FDA). Sunscreen drug products for over-the-counter human use: Request for data and information regarding dosage forms (advance notice of proposed rulemaking), Federal Register 2011). http://69.175.53.6/register/2011/jun/17/2011-14768.pdf. Accessed May 9